Menu
Back to Journals » Biologics: Targets and Therapy » Volume 1 » Issue 1
Palivizumab: a review of its use in the protection of high risk infants against respiratory syncytial virus (RSV)
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,823 | Dovepress* | 5,823+ | 1,743 | 7,566 | |
| Totals | 5,823 | 1,743 | 7,566 | ||
|
*Since 15 August 2007 +Since July 2016 |
|||||
View citations on Google Scholar